Literature DB >> 23228871

A case series of thoracic paravertebral blocks using a combination of ropivacaine, clonidine, epinephrine, and dexamethasone.

Farzin Goravanchi1, Spencer S Kee, Alicia M Kowalski, Joel S Berger, Katy E French.   

Abstract

Five patients who underwent surgery for breast cancer were followed for 6 days after placement of a multiple-injection, one-time paravertebral block. Data were collected on patient satisfaction, analgesic consumption, side effects, and complications. Ropivacaine as a sole agent in paravertebral blocks has a clinical duration of up to 6 hours. The addition of epinephrine, clonidine, and dexamethasone prolonged the clinical duration considerably.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228871     DOI: 10.1016/j.jclinane.2012.05.005

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

1.  Effect of Clonidine as Adjuvant in Thoracic Paravertebral Block for Patients Undergoing Breast Cancer Surgery: A Prospective, Randomized, Placebo-controlled, Double-blind Study.

Authors:  Nairita Mayur; Anjan Das; Hirak Biswas; Subinay Chhaule; Surajit Chattopadhyay; Tapobrata Mitra; Sandip Roybasunia; Subrata Kumar Mandal
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

2.  The impact of intravenous dexamethasone on the efficacy and duration of analgesia of paravertebral block in breast cancer surgery: a randomized controlled trial.

Authors:  Ahmed H Bakeer; Nasr M Abdallah; Mahmoud A Kamel; Dina N Abbas; Ahmed S Ragab
Journal:  J Pain Res       Date:  2018-12-19       Impact factor: 3.133

3.  Efficacy of perineural dexamethasone with ropivacaine in thoracic paravertebral block for postoperative analgesia in elective thoracotomy: a randomized, double-blind, placebo-controlled trial.

Authors:  Yu Mao; Youmei Zuo; Bin Mei; Lijian Chen; Xuesheng Liu; Zhi Zhang; Erwei Gu
Journal:  J Pain Res       Date:  2018-09-11       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.